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Identity 
Other names: CYPIIW1; FLJ20359; MGC34287 
HGNC (Hugo): CYP2W1 
Location: 7p22.3 
Local order: ADAP1 (960811 - 904066 on minus 
strand); COX19 (981761 - 971012 on minus strand); 
CYP2W1; C7orf50 (1144360 - 1003168 on minus 
strand); LOC100130456 (1055992 - 1056381 on plus 
strand); GPR146 (1063667 - 1065423 on plus strand). 
DNA/RNA 
Description 
The CYP2W1 gene has nine exons resulting in an open 
reading frame of 1473 bp. 
Transcription 
At this point five different CYP2W1 transcripts have 
been described in different databases. In particular two 
transcripts have gained interest. The first variant, 
corresponding to the reference sequence, consists of 
nine exons and has a typical cytochrome P450 family 2 
structure, containing conserved features etc. The 
second variant has only eight exons although the eight 
exon is longer in this transcript than in the nine-exon-
transcript. The absence of a conserved cysteine 
indicates that this transcript can not result in a 
functional P450 enzyme (see figure below). 
Pseudogene 





CYP2W1 is a cytochrome P450 enzyme belonging to 
family 2. Other family 2 members are important for the 
metabolism of drugs and other xenobiotics. In 
mammals the P450 enzymes are membrane bound and 
mainly localized to the endoplasmic reticulum (ER) but 
also to the mitochondria.  
Description 
All cytochrome P450 enzymes have a similar fold 
although their sequence identity can be very low. 
Structurally, P450 enzymes have a conserved core 
consisting of a four-helix bundle, including helices D, 
E, I and L, and the two helices J and K. In addition 
there are two sets of conserved beta-sheets containing 
five and two strands respectively. All P450 enzymes 
contain a heme group and one of the few conserved 
residues is a conserved cysteine serving as the fifth 
heme iron ligand. A structural similarity of mammalian 
P450 enzymes is the hydrophobic NH2-terminal part 
spanning the membrane and serving as membrane 
anchor. 
Expression 
CYP2W1 mRNA and/or protein are highly expressed 
in some cancer types including colon, adrenal gland, 
lung and gastric cancers. In addition high CYP2W1 
expression has been detected in two human derived cell 
lines, Caco2-TC7 and HepG2. HepG2 is the cell line 
where CYP2W1 was first identified, however the 
expression levels in Caco2-TC7 exceeds the levels in 
HepG2 cells significantly.  
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Alignment of the deduced CYP2W1 amino acid sequences from human, chimpanzee, rat, mouse, dog and chicken. Human 9e 
corresponds to the CYP2W1 reference sequence consisting of nine exons, whereas human 8e corresponds to the eight-exon-transcript 
mentioned above. For chimpanzee three transcripts are know, here numbered 1-3. All animal sequences correspond to the CYP2W1 
homologous genes listed below. The conserved cysteine serving as the fifth heme iron ligand (mentioned below) is indicated with a red 
box. 
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Some scientists have also reported CYP2W1 mRNA 
expression in various adult human tissues as well as in 
keratinocytes and MCF10A cells, however so far no 
protein has been identified in these tissues/cells, which 
might be an indication of low expression levels. For 
non-human tissues high CYP2W1 mRNA expression 
levels are found in whole mouse embryo and in rat fetal 
colon. The expression in fetal rat colon increased by 
fetal age, whereas the opposite was seen in adult rat 
colon where the expression levels decreased again after 
birth. 
Localisation 
Cytochrome P450 family 2 members are usually 
located in the ER membrane, however CYP2W1 have 
been detected both in microsomes (i.e. ER) and in 
mitochondria. 
Function 
Cytochrome P450 enzymes are monooxidases and as 
mentioned other family 2 enzymes are involved in the 
metabolism of many drugs. The knowledge about 
CYP2W1 substrates are today limited. The substrates 
identified are arachidonic acid, benzfetamine and 
indole. In addition, CYP2W1 has been reported to 
activate a number of procarcinogens, e.g. PAHs, 
aflatoxin B1, sterigmatocystin etc. (for a more detailed 
list see Wu et al., 2006). 
Based on the high CYP2W1 expression in fetal rat 
colon and mouse embryo it is possible that CYP2W1 
has some yet unknown function during 
embryogenesis/differentiation. 
Homology 
- CYP2W1 (Pan troglodytes) 
- Cyp2w1 (Mus musculus) 
- Cyp2w1 (Rattus norvegicus) 
Denoted as similar to CYP2W1: 
- LOC416454 (Gallus gallus) 
- LOC491601 (Canis lupus familiaris) 
Mutations 
Note 
Several SNPs have been detected in the CYP2W1 gene, 
both synonymous and non-synonymous. For an 
updated overview of CYP2W1 polymorphisms and 





CYP2W1 mRNA and/or protein are highly expressed 
in some cancer types, in particular colorectal cancer, 
but also adrenal gland, lung and gastric cancers. In 
addition CYP2W1 mRNA and protein expression has 
been detected in two human derived cancer cell lines, 
Caco2-TC7 (colorectal adenocarcinoma) and HepG2 
(hepatocellular carcinoma). 
Disease 
A recent pilot study shows that CYP2W1 is a 
prognostic marker for overall survival in colon cancer. 
In addition high tumoral CYP2W1 protein expression 
was associated with a worse clinical outcome. 
Previously is has been shown that the overexpression of 
CYP2W1 in cancer tissue could be associated with a 
decreased CpG methylation within the CYP2W1 gene. 
At this point there is no further data regarding 
CYP2W1 and its role in carcinogenesis and/or cancer 
treatment. 
References 
Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman 
JB. Expression patterns of mouse and human CYP orthologs 
(families 1-4) during development and in different adult tissues. 
Arch Biochem Biophys. 2005 Apr 1;436(1):50-61 
Karlgren M, Miura S, Ingelman-Sundberg M. Novel 
extrahepatic cytochrome P450s. Toxicol Appl Pharmacol. 2005 
Sep 1;207(2 Suppl):57-61 
Aung PP, Oue N, Mitani Y, Nakayama H, Yoshida K, Noguchi 
T, Bosserhoff AK, Yasui W. Systematic search for gastric 
cancer-specific genes based on SAGE data: melanoma 
inhibitory activity and matrix metalloproteinase-10 are novel 
prognostic factors in patients with gastric cancer. Oncogene. 
2006 Apr 20;25(17):2546-57 
Du L, Neis MM, Ladd PA, Lanza DL, Yost GS, Keeney DS. 
Effects of the differentiated keratinocyte phenotype on 
expression levels of CYP1-4 family genes in human skin cells. 
Toxicol Appl Pharmacol. 2006 Jun 1;213(2):135-44 
Karlgren M, Gomez A, Stark K, Svärd J, et al. Tumor-specific 
expression of the novel cytochrome P450 enzyme, CYP2W1. 
Biochem Biophys Res Commun. 2006 Mar 10;341(2):451-8 
Thomas RD, Green MR, Wilson C, Weckle AL, Duanmu Z, 
Kocarek TA, Runge-Morris M. Cytochrome P450 expression 
and metabolic activation of cooked food mutagen 2-amino-1-
methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in MCF10A 
breast epithelial cells. Chem Biol Interact. 2006 Apr 
15;160(3):204-16 
Wu ZL, Sohl CD, Shimada T, Guengerich FP. Recombinant 
enzymes overexpressed in bacteria show broad catalytic 
specificity of human cytochrome P450 2W1 and limited activity 
of human cytochrome P450 2S1. Mol Pharmacol. 2006 
Jun;69(6):2007-14 
Yoshioka H, Kasai N, Ikushiro S, Shinkyo R, Kamakura M, 
Ohta M, Inouye K, Sakaki T. Enzymatic properties of human 
CYP2W1 expressed in Escherichia coli. Biochem Biophys Res 
Commun. 2006 Jun 23;345(1):169-74 
Gomez A, Karlgren M, Edler D, Bernal ML, Mkrtchian S, 
Ingelman-Sundberg M. Expression of CYP2W1 in colon 
tumors: regulation by gene methylation. Pharmacogenomics. 
2007 Oct;8(10):1315-25 
Karlgren M, Ingelman-Sundberg M. Tumour-specific 
expression of CYP2W1: its potential as a drug target in cancer 
therapy. Expert Opin Ther Targets. 2007 Jan;11(1):61-7 
Hanzawa Y, Sasaki T, Mizugaki M, Ishikawa M, Hiratsuka M. 
Genetic polymorphisms and haplotype structures of the human 
CYP2W1 gene in a Japanese population. Drug Metab Dispos. 
2008 Feb;36(2):349-52 






Atlas Genet Cytogenet Oncol Haematol. 2010; 14(5)  451 
Edler D, Stenstedt K, Ohrling K, Hallström M, Karlgren M, 
Ingelman-Sundberg M, Ragnhammar P. The expression of the 
novel CYP2W1 enzyme is an independent prognostic factor in 
colorectal cancer - a pilot study. Eur J Cancer. 2009 
Mar;45(4):705-12 
This article should be referenced as such: 
Karlgren M. CYP2W1 (cytochrome P450, family 2, subfamily 
W, polypeptide 1). Atlas Genet Cytogenet Oncol Haematol. 
2010; 14(5):448-451. 
